Core Viewpoint - Dongwu Securities report indicates that the performance of Xinzhou Bang meets market expectations, with projected revenue of 9.64 billion yuan in 2025, representing a year-on-year increase of 22.8%, and a projected net profit attributable to shareholders of 1.1 billion yuan, up 16.6% year-on-year [1] Group 1 - The price increase of electrolyte hexafluorides contributes to performance elasticity, and unit profitability shows significant recovery [1] - In 2026, customer certification for semiconductor cooling liquid products is expected to be largely completed, with anticipated volume growth starting in 2026 [1] - The company expects a reduction in losses from Haidefu in 2026, with fluorochemical products projected to contribute 1 billion yuan in profit, indicating a recovery in growth rate [1] Group 2 - Considering the significant price increases of hexafluoride and VC, unit profitability is expected to show notable recovery in Q4 2025, with further price elasticity anticipated in 2026 [1] - New product contributions from the fluorochemical business are expected to provide incremental growth [1] - A target price of 79.8 yuan is set for 2026, with a maintained "buy" rating based on a 25x PE ratio [1]

Core Viewpoint - Dongwu Securities report indicates that Xinzhou Bang's performance meets market expectations, with projected revenue of 9.64 billion yuan in 2025, representing a year-on-year increase of 22.8%, and a projected net profit attributable to shareholders of 1.1 billion yuan, reflecting a year-on-year growth of 16.6% [1] Group 1 - The price increase of electrolyte hexafluorides contributes to performance elasticity, and unit profitability shows significant recovery [1] - In 2026, customer certification for semiconductor cooling liquid products is expected to be largely completed, with anticipated volume growth starting in 2026 [1] - The company is expected to reduce losses from Haidefu in 2026, with fluorochemical products projected to contribute 1 billion yuan in profit, indicating a recovery in growth rate [1] Group 2 - Considering the significant price increases of hexafluoride and VC, unit profitability is expected to show notable recovery in Q4 2025, with further price elasticity anticipated in 2026 [1] - New product contributions from the fluorochemical business are expected to provide incremental growth [1] - A target price of 79.8 yuan is set for 2026, with a maintained "buy" rating based on a 25x PE ratio [1]